Lycored Files Lycopene Patent Infringement Suit Against Valensa

ORANGE, N.J.LycoRed Limited and Lycored Corp., makers of Lyc-O-Mato® lycopene, have filed a lawsuit against E.I.D. Parry Ltd. and Valensa International for infringement of three patents (U.S. patent nos. 6,515,018; 5,837,311; and 5,965,183) covering lycopene-containing compositions, production process and methods for usage. Lycored alleges Parry/Valensa engaged in acts of infringement by making, using and selling its tomato lycopene products in the United States, and has therefore placed its customers in the position of doing so as well.  Lycored is asking for an injunction to stop sales of, as well as to recall, all products that infringe on the patents. The company is also seeking monetary damages to compensate the company for the unlawful violations.

Parry Nutraceuticals unlawfully leveraged our proprietary science to produce and market its Tomato Lycopene Complex, said Morris Zelkha, president and CEO of LycoRed.  "Parry, however, has not offered any scientific research to demonstrate that its lycopene products have the same clinical attributes as Lyc-O-Mato."